Fampridine Pregnancy Exposure Registry

Mise à jour : Il y a 4 ans
Référence : NCT01532154

Femme Homme

  • | Pays :
  • France
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This is a global pregnancy registry to evaluate the outcomes of pregnancy in women with multiple sclerosis who have been exposed to prolonged-release fampridine since the first day of their last menstrual period prior to conception or at any time during pregnancy.


Critère d'inclusion

  • Multiple sclerosis ,pregnancy

Liens